CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF THE NEW CORONAVIRUS INFECTION COVID-19: DATA FROM A FEDERAL HOSPITAL IN SAMARA REGION
Objective: to analyze clinical and epidemiological characteristics of patients with COVID-19 treated in a federal hospital of Samara region and their association with disease severity. Materials and methods. We analyzed the results of clinical and epidemiological examination of 361 patients with CO...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Private institution educational organization of higher education "Medical University "ReaViz"
2021-02-01
|
| Series: | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
| Subjects: | |
| Online Access: | https://vestnik.reaviz.ru/jour/article/view/74 |
| Summary: | Objective: to analyze clinical and epidemiological characteristics of patients with COVID-19 treated in a federal hospital of Samara region and their association with disease severity. Materials and methods. We analyzed the results of clinical and epidemiological examination of 361 patients with COVID-19 divided into two groups: patients with moderate disease (n = 285) and patients with severe disease (n = 76). All study participants received inpatient treatment in the federal hospital of Samara State Medical University in 2020. The diagnosis was verified using enzyme-linked immunosorbent assay (ELISA) and/or polymerase chain reaction (PCR).Results. There were no significant differences in the gender and age of COVID-19 patients in the two groups compared. Patients in Group 2 were slightly older than those in Group 1 (62.5 years (range: 53.0–68.8) vs 57.0 years (47.0–65.0) (trend; р = 0.008). The disease severity correlated with the time to hospitalization: the longer patients stayed at home, the more likely they developed severe disease. Such symptoms as sore throat and rhinorrhea were associated with a less severe disease, whereas shortness of breath, any changes in consciousness, nausea, and stool disorders on weeks 2–3 of the disease correlated with a more severe course. The proportion of patients with concomitant diseases (especially, more than one) was significantly higher in patients with severe COVID-19 than in patients with moderate COVID-19 (74% vs 63%). |
|---|---|
| ISSN: | 2226-762X 2782-1579 |